Regulation of phosphatidylinositol 3-kinase (PI3K)/Akt and nuclear factor-kappa B signaling pathways in dystrophin-deficient skeletal muscle in response to mechanical stretch

Journal of Cellular Physiology

Volumn 208, Issue 3, 2006, Pages 575-585

  Dogra, Charu ^a   Changotra, Harish ^a   Wergedal, Jon E ^a,b   Kumar, Ashok ^a,b  

^a Jerry L Pettis Memorial VA Medical Center   (United States)

^b LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 3 PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; BETA1 INTEGRIN; CELL PROTEIN; DYSTROPHIN; GLYCOGEN SYNTHASE KINASE 3BETA; HISTONE DEACETYLASE 1; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN 1; INTEGRIN LINKED KINASE; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN BCL 2; PROTEIN KINASE; PROTEIN KINASE B; PROTEIN SUBUNIT; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL SURVIVAL; CONTROLLED STUDY; DIAPHRAGM MUSCLE; DUCHENNE MUSCULAR DYSTROPHY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME REGULATION; IN VITRO STUDY; KNOCKOUT MOUSE; MECHANICAL STIMULATION; MECHANICAL STRETCH; MOUSE; MUSCLE STRETCHING; MYOTUBE; NECROSIS; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; DIAPHRAGM; DYSTROPHIN; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-AKT; REFLEX, STRETCH; SIGNAL TRANSDUCTION;

MAMMALIA;

EID: 33746579821     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20696     Document Type: Article

References (69)

1. Alessi DR, Andjelkovic M, Caudwell B, Cron P, Morrice N, Cohen P, Hemmings BA. 1996. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J 15(23):6541-6551.
2. Alessi DR, James SR, Downes CP, Holmes AB, Gaffney PR, Reese CB, Cohen P. 1997. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha. Curr Biol 7(4):261-269.
3. Altomare DA, Guo K, Cheng JQ, Sonoda G, Walsh K, Testa JR. 1995. Cloning, chromosomal localization and expression analysis of the mouse Akt2 oncogene. Oncogene 11(6):1055-1060.
4. Altomare DA, Lyons GE, Mitsuuchi Y, Cheng JQ, Testa JR. 1998. Akt2 mRNA is highly expressed in embryonic brown fat and the AKT2 kinase is activated by insulin. Oncogene 16(18):2407-2411.
5. Ashburner BP, Westerheide SD, Baldwin AS, Jr. 2001. The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol Cell Biol 21(20):7065-7077.
6. Barton ER, Morris L, Musaro A, Rosenthal N, Sweeney HL. 2002. Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice. J Cell Biol 157:137-148.
7. Bassel-Duby R, Olson EN. 2003. Role of calcineurin in striated muscle: Development, adaptation, and disease. Biochem Biophys Res Commun 311:1133-1141.
8. Bellacosa A, Chan TO, Ahmed NN, Datta K, Malstrom S, Stokoe D, McCormick F, Feng J, Tsichlis P. 1998. Akt activation by growth factors is a multiple-step process: The role of the PH domain. Oncogene 17(3):313-325.
9. Bolster DR, Kimball SR, Jefferson LS. 2003. Translational control mechanisms modulate skeletal muscle gene expression during hypertrophy. Exerc Sport Sci Rev 31(3):111-116.
10. Boppart MD, Hirshman MF, Sakamoto K, Fielding RA, Goodyear LJ. 2001. Static stretch increases c-Jun NH2-terminal kinase activity and p38 phosphorylation in rat lung parenchyma. Am J Physiol Cell Physiol 280:C352-C358.
11. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME. 1999. Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor. Cell 96:857-868.
12. Choi YS, Jeong S. 2005. PI3-kinase and PDK-1 regulate HDAC1-mediated transcriptional repression of transcription factor NF-kappaB. Mol Cells 20(2):241-246.
13. Craig SW, Pardo JV. 1983. Gamma actin spectrin and intermediate. Cell Motil 3:449-462.
14. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. 1995. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378(6559):785-789.
15. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME. 1997. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91:231-241.
16. Datta SR, Brunet A, Greenberg ME. 1999. Cellular survival: A play in three Akts. Genes Dev 13:2905-2927.
17. Deprez J, Vertommen D, Alessi DR, Hue L, Rider MH. 1997. Phosphorylation and activation of heart 6-phosphofructo-2-kinase by protein kinase B and other protein kinases of the insulin signaling cascades. J Biol Chem 272(28):17269-17275.
18. Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao R, Cooper GM, Segal KA, Kaplan DR, Greenberg ME, 1997. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275(5300):661-665.
19. Franke TF, Kaplan DR, Cantley LC. 1997. PI3K: Downstream AKTion blocks apoptosis. Cell 88(4):435-437.
20. Gustin JA, Ozes ON, Akca H, Pincheira R, Mayo LD, Li Q, Guzman JR, Korgaonkar CK, Donner DB. 2004. Cell type-specific expression of the IkappaB kinases determines the significance of phosphatidylinositol 3-kinase/Akt signaling to NF-kappa B activation. J Biol Chem 279(3):1615-1620.
21. Henry MD, Campbell KP. 1996. Dystroglycan: An extracellular matrix receptor linked to the cytoskeleton. Curr Opin Cell Biol 8(5):625-631.
22. Hodges BL, Hayashi YK, Nonaka I, Wang W, Arahata K, Kaufman SJ. 1997. Altered expression of the alpha7beta1 integrin in human and murine muscular dystrophies. J Cell Sci 110(Pt 22):2873-2881.
23. Hoffman EP, Brown RH, Kunkel LM. 1987a. Dystrophin: The protein product of the Duchenne muscular dystrophy locus. Cell 51:919-928.
24. Hoffman EP, Monaco AP, Feener CC, Kunkel LM. 1987b. Conservation of the Duchenne muscular dystrophy gene in mice and humans. Science 238(4825):347-350.
25. Hornberger TA, Stuppard R, Conley KE, Fedele MJ, Fiorotto ML, Chin ER, Esser KA. 2004. Mechanical stimuli regulate rapamycin-sensitive signalling by a phosphoinositide 3-kinase-, protein kinase B- and growth factor-independent mechanism. Biochem J 380(Pt 3):795-804.
26. Jung D, Yang B, Meyer J, Chamberlain JS, Campbell KP. 1995. Identification and characterization of the dystrophin anchoring site on beta-dystroglycan. J Biol Chem 270:27305-27310.
27. Kandarian SC, Jackman RW. 2006. Intracellular signaling during skeletal muscle atrophy. Muscle Nerve 33:155-165.
28. Kane LP, Shapiro VS, Stokoe D, Weiss A. 1999. Induction of NF-kappaB by the Akt/PKB kinase. Curr Biol 9:601-604.
29. Karin M, Lin A. 2002. NF-kappaB at the crossroads of life and death. Nat Immunol 3:221-227.
30. Kulik G, Klippel A, Weber MJ. 1997. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Mol Cell Biol 17(3):1595-1606.
31. Kumar A, Boriek AM. 2003. Mechanical stress activates the nuclear factor-kappaB pathway in skeletal muscle fibers: A possible role in Duchenne muscular dystrophy. FASEB J 17:386-396.
32. Kumar A, Chaudhry I, Reid MB, Boriek AM. 2002. Distinct signaling pathways are activated in response to mechanical stress applied axially and transversely to skeletal muscle fibers. J Biol Chem 277(48):46493-46503.
33. Kumar A, Lnu S, Malya R, Barron D, Moore J, Corry DB, Boriek AM. 2003. Mechanical stretch activates nuclear factor-kappaB, activator protein-1, and mitogen-activated protein kinases in lung parenchyma: Implications in asthma. FASEB J 17:1800-1811.
34. Kumar A, Khandelwal N, Malya R, Reid MB, Boriek AM. 2004a. Loss of dystrophin causes aberrant mechanotransduction in skeletal muscle fibers. FASEB J 18:102-113.
35. Kumar A, Murphy R, Robinson P, Wei L, Boriek AM. 2004b. Cyclic mechanical strain inhibits skeletal myogenesis through activation of focal adhesion kinase, Rac-1 GTPase, and NF-kappaB transcription factor. FASEB J 18:1524-1535.
36. Kumar A, Takada Y, Boriek AM, Aggarwal BB. 2004c. Nuclear factor-kappa B: Its role in health and disease. J Mol Med 82:434-448.
37. Lawlor M, Alessi D. 2001. PKB/Akt: A key mediator of cell proliferation, survival and insulin responses? J Cell Sci 114:2903-2910.
38. Madrid LV, Wang CY, Guttridge DC, Schottelius AJ, Baldwin AS, Jr., Mayo MW. 2000. Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappaB. Mol Cell Biol 20(5):1626-1638.
39. Madrid LV, Mayo MW, Reuther JY, Baldwin AS, Jr. 2001. Akt stimulates the transactivation potential of the RelA/p65 subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38. J Biol Chem 276(22):18934-18940.
40. Moule SK, Welsh GI, Edgell NJ, Foulstone EJ, Proud CG, Denton RM. 1997. Regulation of protein kinase B and glycogen synthase kinase-3 by insulin and beta-adrenergic agonists in rat epididymal fat cells. Activation of protein kinase B by wortmannin-sensitive and -insensitive mechanisms. J Biol Chem 272(12):7713-7719.
41. Nader GA, Hornberger TA, Esser KA. 2002. Translational control: Implications for skeletal muscle hypertrophy. Clin Orthop Relat Res 403:S178-S187.
42. Nobe K, Paul RJ. 2001. Distinct pathways of Ca(2+) sensitization in porcine coronary artery: Effects of Rho-related kinase and protein kinase C inhibition on force and intracellular Ca(2+). Circ Res 88:1283-1290.
43. Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner DB. 1999. NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401(6748):82-85.
44. Persad S, Attwell S, Gray V, Delcommenne M, Troussard A, Sanghera J, Dedhar S. 2000. Inhibition of integrin-linked kinase (ILK) suppresses activation of protein kinase B/Akt and induces cell cycle arrest and apoptosis of PTEN-mutant prostate cancer cells. Proc Natl Acad Sci USA 97(7):3207-3212.
45. Proske U, Morgan DL. 2001. Muscle damage from eccentric exercise: Mechanism, mechanical signs, adaptation and clinical applications. J Physiol 537:333-345.
46. Rando TA. 2001. The dystrophin-glycoprotein complex, cellular signaling, and the regulation of cell survival in the muscular dystrophies. Muscle Nerve 24(12):1575-1594.
47. Romashkova JA, Makarov SS. 1999. NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature 401(6748):86-90.
48. Ruwhof C, van der Laarse A. 2000. Mechanical stress-induced cardiac hypertrophy: Mechanisms and signal transduction pathways. Cardiovasc Res 47:23-37.
49. Rybakova IN, Amann KJ, Ervasti JM. 1996. A new model for the interaction of dystrophin with F-actin. J Cell Biol 137:661-672.
50. Sakamoto K, Hirshman MF, Aschenbach WG, Goodyear LJ. 2002. Contraction regulation of Akt in rat skeletal muscle. J Biol Chem 277(14):11910-11917.
51. Sakamoto K, Aschenbach WG, Hirshman MF, Goodyear LJ. 2003. Akt signaling in skeletal muscle: Regulation by exercise and passive stretch. Am J Physiol Endocrinol Metab 285(5):E1081-E1088.
52. Sakamoto K, Arnolds DE, Ekberg I, Thorell A, Goodyear LJ. 2004. Exercise regulates Akt and glycogen synthase kinase-3 activities in human skeletal muscle. Biochem Biophys Res Commun 319(2):419-425.
53. Sakaue H, Ogawa W, Takata M, Kuroda S, Kotani K, Matsumoto M, Sakaue M, Nishio S, Ueno H, Kasuga M. 1997. Phosphoinositide 3-kinase is required for insulin-induced but not for growth hormone- or hyperosmolarity-induced glucose uptake in 3T3-L1 adipocytes. Mol Endocrinol 11(10):1552-1562.
54. Schlaepfer DD, Hauck CR, Sieg DJ. 1999. Signaling through focal adhesion kinase. Prog Biophys Mol Biol 71(3-4):435-478.
55. Scott PH, Brunn GJ, Kohn AD, Roth RA, Lawrence JC, Jr. 1998. Evidence of insulin-stimulated phosphorylation and activation of the mammalian target of rapamycin mediated by a protein kinase B signaling pathway. Proc Natl Acad Sci USA 95(13):7772-7777.
56. Sekulic A, Hudson CC, Homme JL, Yin P, Otterness DM, Karnitz LM, Abraham RT. 2000. A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells. Cancer Res 60(13):3504-3513.
57. Song G, Ouyang G, Bao S. 2005. The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med 9(1):59-71.
58. Stedman HH, Sweeney HL, Shrager JB, Maguire HC, Panettieri RA, Petrof B, Narusawa M, Leferovich JM, Sladky JT, Kelly AM. 1991. The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature 352(6335):536-539.
59. Tanaka H, Fujita N, Tsuruo T. 2005. PDK1-mediated IKKbeta phosphorylation activates NF-kappa B signaling. J Biol Chem 280:40965-40973.
60. Testa JR, Bellacosa A. 2001. AKT plays a central role in tumorigenesis. Proc Natl Acad Sci USA 98(20):10983-10985.
61. Tidball JG, Albrecht DE, Lokensgard BE, Spencer MJ. 1995. Apoptosis precedes necrosis of dystrophin-deficient muscle. J Cell Sci 108:2197-2204.
62. Tidball JG, Lavergne E, Lau KS, Spencer MJ, Stull JT, Wehling M. 1998. Mechanical loading regulates NOS expression and activity in developing and adult skeletal muscle. Am J Physiol 275:C260-C266.
63. Tidball JG, Spencer MJ, Wehling M, Lavergne E. 1999. Nitric oxide synthase is a mechanical signal transducer that modulates talin and vinculin in expression. J Biol Chem 274:33155-33160.
64. Toker A, Cantley LC. 1997. Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature 387(6634):673-676.
65. Walker KS, Deak M, Paterson A, Hudson K, Cohen P, Alessi DR. 1998. Activation of protein kinase B beta and gamma isoforms by insulin in vivo and by 3-phosphoinositide-dependent protein kinase-1 in vitro: Comparison with protein kinase B alpha. Biochem J 331(Pt 1):299-308.
66. Wedhas N, Klamut HJ, Dogra C, Srivastava AK, Mohan S, Kumar A. 2005. Inhibition of mechanosensitive cation channels inhibits myogenic differentiation by suppressing the expression of myogenic regulatory factors and caspase-3 activity. FASEB J 19(14):1986-1997.
67. Yano S, Tokumitsu H, Soderling TR. 1998. Calcium promotes cell survival through CaM-K kinase activation of the protein-kinase-B pathway. Nature 396(6711):584-587.
68. Yao R, Cooper GM. 1995. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science 267(5206):2003-2006.
69. Zhong H, May MJ, Jimi E, Ghosh S. 2002. The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol Cell 9(3):625-636.